The dosimetric results and findings described in the T/B ratios of the primary and metastatic lesions suggest that [99mTc]Tc-iFAP imaging is a safe and potentially useful tool to assess FAP expression in the tumor microenvironment of various solid tumors, such as breast, lung, and cervical cancer. The gene discussed is FAP; the disease is cervical carcinoma.